high expression of UsP 22 predicts poor prognosis and advanced clinicopathological features in solid tumors : a meta-analysis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4

  2017cited by this paper
• Deubiquitinating enzyme USP22 positively regulates c‐Myc stability and tumorigenic activity in mammalian and breast cancer cells

  2017cited by this paper
• USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt

  2017cited by this paper
• Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma

  2016cited by this paper
• High USP22 expression indicates poor prognosis in hepatocellular carcinoma

  2015cited by this paper
• Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

  2015cited by this paper
• Decreased H2B monoubiquitination and overexpression of ubiquitin-specific protease enzyme 22 in malignant colon carcinoma.

  2015cited by this paper
• USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.

  2015cited by this paper
• Ubiquitin‑specific protease 22‑induced autophagy is correlated with poor prognosis of pancreatic cancer.

  2014cited by this paper
• Ubiquitin-Specific Peptidase 22, a Histone Deubiquitinating Enzyme, Is a Novel Poor Prognostic Factor for Salivary Adenoid Cystic Carcinoma

  2014cited by this paper
• Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics

  2014cited by this paper
• Cancer survival: global surveillance will stimulate health policy and improve equity.

  2014cited by this paper
• USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma

  2014cited by this paper
• Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics

  2014cited by this paper
• Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma

  2013cited by this paper
• A High-Confidence Interaction Map Identifies SIRT1 as a Mediator of Acetylation of USP22 and the SAGA Coactivator Complex

  2013cited by this paper
• Increased expression of USP22 is associated with disease progression and patient prognosis of salivary duct carcinoma.

  2013cited by this paper
• The ubiquitin hydrolase, USP22 contributes to 3’-end processing of JAK-STAT inducible genes

  2013cited by this paper
• USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma

  2012cited by this paper
• USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development.

  2012cited by this paper
• Inter-rater and test–retest reliability of quality assessments by novice student raters using the Jadad and Newcastle–Ottawa Scales

  2012cited by this paper
• USP22 Is Useful as a Novel Molecular Marker for Predicting Disease Progression and Patient Prognosis of Oral Squamous Cell Carcinoma

  2012cited by this paper
• Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer

  2012cited by this paper
• USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1

  2011cited by this paper
• The Co-expression of USP22 and BMI-1 May Promote Cancer Progression and Predict Therapy Failure in Gastric Carcinoma

  2011cited by this paper
• Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer

  2011cited by this paper
• Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer

  2011cited by this paper
• Implication of USP22 in the Regulation of BMI-1, c-Myc, p16INK4a, p14ARF, and Cyclin D2 Expression in Primary Colorectal Carcinomas

  2010cited by this paper
• Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells

  2010cited by this paper
• Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients

  2010cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Targeting the ubiquitin system in cancer therapy

  2009cited by this paper
• Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.

  2009cited by this paper
• "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.

  2008cited by this paper
• The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression.

  2008cited by this paper
• Dubbing SAGA unveils new epigenetic crosstalk.

  2008cited by this paper
• The complex language of chromatin regulation during transcription

  2007cited by this paper
• Mechanisms, biology and inhibitors of deubiquitinating enzymes.

  2007cited by this paper
• An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non–Small Cell Lung Cancers

  2006cited by this paper
• Genomic Models of Metastatic Cancer: Functional Analysis of Death-from-Cancer Signature Genes Reveals Aneuploid, Anoikis-Resistant, Metastasis-Enabling Phenotype with Altered Cell Cycle Control and Activated PcG Protein Chromatin Silencing Pathway

  2006cited by this paper
• Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a).

  2006cited by this paper
• Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

  2005cited by this paper
• The history of cancer epigenetics

  2004cited by this paper
• Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

  2001influential reference

• Clinicopathological and Prognostic Value of USP22 Expression in Gastric Cancer: A Systematic Review and Meta-Analysis and Database Validation

  2022cites this paper
• The SAGA complex regulates early steps in transcription via its deubiquitylase module subunit USP22

  2021cites this paper
• RETRACTED ARTICLE: The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer

  2020cites this paper
• Calpain Small Subunit 1 Protein in the Prognosis of Cancer Survivors and Its Clinicopathological Correlation

  2019cites this paper